The global Injectable Nanomedicines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Injectable Nanomedicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Nanomedicines.

Report Scope

The Injectable Nanomedicines market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Nanomedicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Nanomedicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Injectable Nanomedicines Market Report

Report Metric	Details
Report Name	Injectable Nanomedicines Market
CAGR	5%
Segment by Type	Liposomes Micelles Nanocrystals Polymeric Nanoparticles Other
Segment by Application	Cancer Central Nervous System Disease Cardiovascular Disease Infection Control Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Lupin, Pacira Pharmaceuticals, Celgene Pharmaceutical, Amgen, Janssen Biotech, Pfizer, Hoffmann-La Roche, Teva Pharmaceutical Industries, Bausch & Lomb
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Nanomedicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Nanomedicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Injectable Nanomedicines Market report?

Ans: The main players in the Injectable Nanomedicines Market are Merck, Lupin, Pacira Pharmaceuticals, Celgene Pharmaceutical, Amgen, Janssen Biotech, Pfizer, Hoffmann-La Roche, Teva Pharmaceutical Industries, Bausch & Lomb

What are the Application segmentation covered in the Injectable Nanomedicines Market report?

Ans: The Applications covered in the Injectable Nanomedicines Market report are Cancer, Central Nervous System Disease, Cardiovascular Disease, Infection Control, Other

What are the Type segmentation covered in the Injectable Nanomedicines Market report?

Ans: The Types covered in the Injectable Nanomedicines Market report are Liposomes, Micelles, Nanocrystals, Polymeric Nanoparticles, Other

1 Injectable Nanomedicines Market Overview

1.1 Product Overview and Scope of Injectable Nanomedicines

1.2 Injectable Nanomedicines Segment by Type

1.2.1 Global Injectable Nanomedicines Market Value Comparison by Type (2024-2030)

1.2.2 Liposomes

1.2.3 Micelles

1.2.4 Nanocrystals

1.2.5 Polymeric Nanoparticles

1.2.6 Other

1.3 Injectable Nanomedicines Segment by Application

1.3.1 Global Injectable Nanomedicines Market Value by Application: (2024-2030)

1.3.2 Cancer

1.3.3 Central Nervous System Disease

1.3.4 Cardiovascular Disease

1.3.5 Infection Control

1.3.6 Other

1.4 Global Injectable Nanomedicines Market Size Estimates and Forecasts

1.4.1 Global Injectable Nanomedicines Revenue 2019-2030

1.4.2 Global Injectable Nanomedicines Sales 2019-2030

1.4.3 Global Injectable Nanomedicines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Injectable Nanomedicines Market Competition by Manufacturers

2.1 Global Injectable Nanomedicines Sales Market Share by Manufacturers (2019-2024)

2.2 Global Injectable Nanomedicines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Injectable Nanomedicines Average Price by Manufacturers (2019-2024)

2.4 Global Injectable Nanomedicines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Injectable Nanomedicines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Injectable Nanomedicines, Product Type & Application

2.7 Injectable Nanomedicines Market Competitive Situation and Trends

2.7.1 Injectable Nanomedicines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Injectable Nanomedicines Players Market Share by Revenue

2.7.3 Global Injectable Nanomedicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Injectable Nanomedicines Retrospective Market Scenario by Region

3.1 Global Injectable Nanomedicines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Injectable Nanomedicines Global Injectable Nanomedicines Sales by Region: 2019-2030

3.2.1 Global Injectable Nanomedicines Sales by Region: 2019-2024

3.2.2 Global Injectable Nanomedicines Sales by Region: 2025-2030

3.3 Global Injectable Nanomedicines Global Injectable Nanomedicines Revenue by Region: 2019-2030

3.3.1 Global Injectable Nanomedicines Revenue by Region: 2019-2024

3.3.2 Global Injectable Nanomedicines Revenue by Region: 2025-2030

3.4 North America Injectable Nanomedicines Market Facts & Figures by Country

3.4.1 North America Injectable Nanomedicines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Injectable Nanomedicines Sales by Country (2019-2030)

3.4.3 North America Injectable Nanomedicines Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Injectable Nanomedicines Market Facts & Figures by Country

3.5.1 Europe Injectable Nanomedicines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Injectable Nanomedicines Sales by Country (2019-2030)

3.5.3 Europe Injectable Nanomedicines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Injectable Nanomedicines Market Facts & Figures by Country

3.6.1 Asia Pacific Injectable Nanomedicines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Injectable Nanomedicines Sales by Country (2019-2030)

3.6.3 Asia Pacific Injectable Nanomedicines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Injectable Nanomedicines Market Facts & Figures by Country

3.7.1 Latin America Injectable Nanomedicines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Injectable Nanomedicines Sales by Country (2019-2030)

3.7.3 Latin America Injectable Nanomedicines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Injectable Nanomedicines Market Facts & Figures by Country

3.8.1 Middle East and Africa Injectable Nanomedicines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Injectable Nanomedicines Sales by Country (2019-2030)

3.8.3 Middle East and Africa Injectable Nanomedicines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Injectable Nanomedicines Sales by Type (2019-2030)

4.1.1 Global Injectable Nanomedicines Sales by Type (2019-2024)

4.1.2 Global Injectable Nanomedicines Sales by Type (2025-2030)

4.1.3 Global Injectable Nanomedicines Sales Market Share by Type (2019-2030)

4.2 Global Injectable Nanomedicines Revenue by Type (2019-2030)

4.2.1 Global Injectable Nanomedicines Revenue by Type (2019-2024)

4.2.2 Global Injectable Nanomedicines Revenue by Type (2025-2030)

4.2.3 Global Injectable Nanomedicines Revenue Market Share by Type (2019-2030)

4.3 Global Injectable Nanomedicines Price by Type (2019-2030)

5 Segment by Application

5.1 Global Injectable Nanomedicines Sales by Application (2019-2030)

5.1.1 Global Injectable Nanomedicines Sales by Application (2019-2024)

5.1.2 Global Injectable Nanomedicines Sales by Application (2025-2030)

5.1.3 Global Injectable Nanomedicines Sales Market Share by Application (2019-2030)

5.2 Global Injectable Nanomedicines Revenue by Application (2019-2030)

5.2.1 Global Injectable Nanomedicines Revenue by Application (2019-2024)

5.2.2 Global Injectable Nanomedicines Revenue by Application (2025-2030)

5.2.3 Global Injectable Nanomedicines Revenue Market Share by Application (2019-2030)

5.3 Global Injectable Nanomedicines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Injectable Nanomedicines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck Injectable Nanomedicines Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Lupin

6.2.1 Lupin Corporation Information

6.2.2 Lupin Description and Business Overview

6.2.3 Lupin Injectable Nanomedicines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Lupin Injectable Nanomedicines Product Portfolio

6.2.5 Lupin Recent Developments/Updates

6.3 Pacira Pharmaceuticals

6.3.1 Pacira Pharmaceuticals Corporation Information

6.3.2 Pacira Pharmaceuticals Description and Business Overview

6.3.3 Pacira Pharmaceuticals Injectable Nanomedicines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Pacira Pharmaceuticals Injectable Nanomedicines Product Portfolio

6.3.5 Pacira Pharmaceuticals Recent Developments/Updates

6.4 Celgene Pharmaceutical

6.4.1 Celgene Pharmaceutical Corporation Information

6.4.2 Celgene Pharmaceutical Description and Business Overview

6.4.3 Celgene Pharmaceutical Injectable Nanomedicines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Celgene Pharmaceutical Injectable Nanomedicines Product Portfolio

6.4.5 Celgene Pharmaceutical Recent Developments/Updates

6.5 Amgen

6.5.1 Amgen Corporation Information

6.5.2 Amgen Description and Business Overview

6.5.3 Amgen Injectable Nanomedicines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Amgen Injectable Nanomedicines Product Portfolio

6.5.5 Amgen Recent Developments/Updates

6.6 Janssen Biotech

6.6.1 Janssen Biotech Corporation Information

6.6.2 Janssen Biotech Description and Business Overview

6.6.3 Janssen Biotech Injectable Nanomedicines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Janssen Biotech Injectable Nanomedicines Product Portfolio

6.6.5 Janssen Biotech Recent Developments/Updates

6.7 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Injectable Nanomedicines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer Injectable Nanomedicines Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Hoffmann-La Roche

6.8.1 Hoffmann-La Roche Corporation Information

6.8.2 Hoffmann-La Roche Description and Business Overview

6.8.3 Hoffmann-La Roche Injectable Nanomedicines Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Hoffmann-La Roche Injectable Nanomedicines Product Portfolio

6.8.5 Hoffmann-La Roche Recent Developments/Updates

6.9 Teva Pharmaceutical Industries

6.9.1 Teva Pharmaceutical Industries Corporation Information

6.9.2 Teva Pharmaceutical Industries Description and Business Overview

6.9.3 Teva Pharmaceutical Industries Injectable Nanomedicines Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Teva Pharmaceutical Industries Injectable Nanomedicines Product Portfolio

6.9.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.10 Bausch & Lomb

6.10.1 Bausch & Lomb Corporation Information

6.10.2 Bausch & Lomb Description and Business Overview

6.10.3 Bausch & Lomb Injectable Nanomedicines Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Bausch & Lomb Injectable Nanomedicines Product Portfolio

6.10.5 Bausch & Lomb Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Injectable Nanomedicines Industry Chain Analysis

7.2 Injectable Nanomedicines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Injectable Nanomedicines Production Mode & Process

7.4 Injectable Nanomedicines Sales and Marketing

7.4.1 Injectable Nanomedicines Sales Channels

7.4.2 Injectable Nanomedicines Distributors

7.5 Injectable Nanomedicines Customers

8 Injectable Nanomedicines Market Dynamics

8.1 Injectable Nanomedicines Industry Trends

8.2 Injectable Nanomedicines Market Drivers

8.3 Injectable Nanomedicines Market Challenges

8.4 Injectable Nanomedicines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

Lupin Ltd

Pacira Pharmaceuticals

Celgene Pharmaceutical

Teva Pharmaceutical Industries

Bausch & Lomb

List of Tables

Table 1. Global Injectable Nanomedicines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Injectable Nanomedicines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Injectable Nanomedicines Market Competitive Situation by Manufacturers in 2023

Table 4. Global Injectable Nanomedicines Sales (MT) of Key Manufacturers (2019-2024)

Table 5. Global Injectable Nanomedicines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Injectable Nanomedicines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Injectable Nanomedicines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Injectable Nanomedicines Average Price (USD/Kg) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Injectable Nanomedicines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Injectable Nanomedicines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Injectable Nanomedicines, Product Type & Application

Table 12. Global Key Manufacturers of Injectable Nanomedicines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Injectable Nanomedicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Nanomedicines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Injectable Nanomedicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Injectable Nanomedicines Sales by Region (2019-2024) & (MT)

Table 18. Global Injectable Nanomedicines Sales Market Share by Region (2019-2024)

Table 19. Global Injectable Nanomedicines Sales by Region (2025-2030) & (MT)

Table 20. Global Injectable Nanomedicines Sales Market Share by Region (2025-2030)

Table 21. Global Injectable Nanomedicines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Injectable Nanomedicines Revenue Market Share by Region (2019-2024)

Table 23. Global Injectable Nanomedicines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Injectable Nanomedicines Revenue Market Share by Region (2025-2030)

Table 25. North America Injectable Nanomedicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Injectable Nanomedicines Sales by Country (2019-2024) & (MT)

Table 27. North America Injectable Nanomedicines Sales by Country (2025-2030) & (MT)

Table 28. North America Injectable Nanomedicines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Injectable Nanomedicines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Injectable Nanomedicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Injectable Nanomedicines Sales by Country (2019-2024) & (MT)

Table 32. Europe Injectable Nanomedicines Sales by Country (2025-2030) & (MT)

Table 33. Europe Injectable Nanomedicines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Injectable Nanomedicines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Injectable Nanomedicines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Injectable Nanomedicines Sales by Region (2019-2024) & (MT)

Table 37. Asia Pacific Injectable Nanomedicines Sales by Region (2025-2030) & (MT)

Table 38. Asia Pacific Injectable Nanomedicines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Injectable Nanomedicines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Injectable Nanomedicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Injectable Nanomedicines Sales by Country (2019-2024) & (MT)

Table 42. Latin America Injectable Nanomedicines Sales by Country (2025-2030) & (MT)

Table 43. Latin America Injectable Nanomedicines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Injectable Nanomedicines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Injectable Nanomedicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Injectable Nanomedicines Sales by Country (2019-2024) & (MT)

Table 47. Middle East & Africa Injectable Nanomedicines Sales by Country (2025-2030) & (MT)

Table 48. Middle East & Africa Injectable Nanomedicines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Injectable Nanomedicines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Injectable Nanomedicines Sales (MT) by Type (2019-2024)

Table 51. Global Injectable Nanomedicines Sales (MT) by Type (2025-2030)

Table 52. Global Injectable Nanomedicines Sales Market Share by Type (2019-2024)

Table 53. Global Injectable Nanomedicines Sales Market Share by Type (2025-2030)

Table 54. Global Injectable Nanomedicines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Injectable Nanomedicines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Injectable Nanomedicines Revenue Market Share by Type (2019-2024)

Table 57. Global Injectable Nanomedicines Revenue Market Share by Type (2025-2030)

Table 58. Global Injectable Nanomedicines Price (USD/Kg) by Type (2019-2024)

Table 59. Global Injectable Nanomedicines Price (USD/Kg) by Type (2025-2030)

Table 60. Global Injectable Nanomedicines Sales (MT) by Application (2019-2024)

Table 61. Global Injectable Nanomedicines Sales (MT) by Application (2025-2030)

Table 62. Global Injectable Nanomedicines Sales Market Share by Application (2019-2024)

Table 63. Global Injectable Nanomedicines Sales Market Share by Application (2025-2030)

Table 64. Global Injectable Nanomedicines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Injectable Nanomedicines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Injectable Nanomedicines Revenue Market Share by Application (2019-2024)

Table 67. Global Injectable Nanomedicines Revenue Market Share by Application (2025-2030)

Table 68. Global Injectable Nanomedicines Price (USD/Kg) by Application (2019-2024)

Table 69. Global Injectable Nanomedicines Price (USD/Kg) by Application (2025-2030)

Table 70. Merck Corporation Information

Table 71. Merck Description and Business Overview

Table 72. Merck Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 73. Merck Injectable Nanomedicines Product

Table 74. Merck Recent Developments/Updates

Table 75. Lupin Corporation Information

Table 76. Lupin Description and Business Overview

Table 77. Lupin Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 78. Lupin Injectable Nanomedicines Product

Table 79. Lupin Recent Developments/Updates

Table 80. Pacira Pharmaceuticals Corporation Information

Table 81. Pacira Pharmaceuticals Description and Business Overview

Table 82. Pacira Pharmaceuticals Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 83. Pacira Pharmaceuticals Injectable Nanomedicines Product

Table 84. Pacira Pharmaceuticals Recent Developments/Updates

Table 85. Celgene Pharmaceutical Corporation Information

Table 86. Celgene Pharmaceutical Description and Business Overview

Table 87. Celgene Pharmaceutical Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 88. Celgene Pharmaceutical Injectable Nanomedicines Product

Table 89. Celgene Pharmaceutical Recent Developments/Updates

Table 90. Amgen Corporation Information

Table 91. Amgen Description and Business Overview

Table 92. Amgen Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 93. Amgen Injectable Nanomedicines Product

Table 94. Amgen Recent Developments/Updates

Table 95. Janssen Biotech Corporation Information

Table 96. Janssen Biotech Description and Business Overview

Table 97. Janssen Biotech Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 98. Janssen Biotech Injectable Nanomedicines Product

Table 99. Janssen Biotech Recent Developments/Updates

Table 100. Pfizer Corporation Information

Table 101. Pfizer Description and Business Overview

Table 102. Pfizer Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 103. Pfizer Injectable Nanomedicines Product

Table 104. Pfizer Recent Developments/Updates

Table 105. Hoffmann-La Roche Corporation Information

Table 106. Hoffmann-La Roche Description and Business Overview

Table 107. Hoffmann-La Roche Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 108. Hoffmann-La Roche Injectable Nanomedicines Product

Table 109. Hoffmann-La Roche Recent Developments/Updates

Table 110. Teva Pharmaceutical Industries Corporation Information

Table 111. Teva Pharmaceutical Industries Description and Business Overview

Table 112. Teva Pharmaceutical Industries Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 113. Teva Pharmaceutical Industries Injectable Nanomedicines Product

Table 114. Teva Pharmaceutical Industries Recent Developments/Updates

Table 115. Bausch & Lomb Corporation Information

Table 116. Bausch & Lomb Description and Business Overview

Table 117. Bausch & Lomb Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 118. Bausch & Lomb Injectable Nanomedicines Product

Table 119. Bausch & Lomb Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Injectable Nanomedicines Distributors List

Table 123. Injectable Nanomedicines Customers List

Table 124. Injectable Nanomedicines Market Trends

Table 125. Injectable Nanomedicines Market Drivers

Table 126. Injectable Nanomedicines Market Challenges

Table 127. Injectable Nanomedicines Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Injectable Nanomedicines

Figure 2. Global Injectable Nanomedicines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Injectable Nanomedicines Market Share by Type in 2023 & 2030

Figure 4. Liposomes Product Picture

Figure 5. Micelles Product Picture

Figure 6. Nanocrystals Product Picture

Figure 7. Polymeric Nanoparticles Product Picture

Figure 8. Other Product Picture

Figure 9. Global Injectable Nanomedicines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Injectable Nanomedicines Market Share by Application in 2023 & 2030

Figure 11. Cancer

Figure 12. Central Nervous System Disease

Figure 13. Cardiovascular Disease

Figure 14. Infection Control

Figure 15. Other

Figure 16. Global Injectable Nanomedicines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Injectable Nanomedicines Market Size (2019-2030) & (US$ Million)

Figure 18. Global Injectable Nanomedicines Sales (2019-2030) & (MT)

Figure 19. Global Injectable Nanomedicines Average Price (USD/Kg) & (2019-2030)

Figure 20. Injectable Nanomedicines Report Years Considered

Figure 21. Injectable Nanomedicines Sales Share by Manufacturers in 2023

Figure 22. Global Injectable Nanomedicines Revenue Share by Manufacturers in 2023

Figure 23. The Global 5 and 10 Largest Injectable Nanomedicines Players: Market Share by Revenue in 2023

Figure 24. Injectable Nanomedicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 25. Global Injectable Nanomedicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 26. North America Injectable Nanomedicines Sales Market Share by Country (2019-2030)

Figure 27. North America Injectable Nanomedicines Revenue Market Share by Country (2019-2030)

Figure 28. U.S. Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Canada Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Europe Injectable Nanomedicines Sales Market Share by Country (2019-2030)

Figure 31. Europe Injectable Nanomedicines Revenue Market Share by Country (2019-2030)

Figure 32. Germany Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. France Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. U.K. Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Italy Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Russia Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Injectable Nanomedicines Sales Market Share by Region (2019-2030)

Figure 38. Asia Pacific Injectable Nanomedicines Revenue Market Share by Region (2019-2030)

Figure 39. China Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Japan Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. South Korea Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. India Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Australia Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Taiwan Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Indonesia Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Thailand Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Malaysia Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Philippines Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Latin America Injectable Nanomedicines Sales Market Share by Country (2019-2030)

Figure 50. Latin America Injectable Nanomedicines Revenue Market Share by Country (2019-2030)

Figure 51. Mexico Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Brazil Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Argentina Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Middle East & Africa Injectable Nanomedicines Sales Market Share by Country (2019-2030)

Figure 55. Middle East & Africa Injectable Nanomedicines Revenue Market Share by Country (2019-2030)

Figure 56. Turkey Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. U.A.E Injectable Nanomedicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Global Sales Market Share of Injectable Nanomedicines by Type (2019-2030)

Figure 60. Global Revenue Market Share of Injectable Nanomedicines by Type (2019-2030)

Figure 61. Global Injectable Nanomedicines Price (USD/Kg) by Type (2019-2030)

Figure 62. Global Sales Market Share of Injectable Nanomedicines by Application (2019-2030)

Figure 63. Global Revenue Market Share of Injectable Nanomedicines by Application (2019-2030)

Figure 64. Global Injectable Nanomedicines Price (USD/Kg) by Application (2019-2030)

Figure 65. Injectable Nanomedicines Value Chain

Figure 66. Injectable Nanomedicines Production Process

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Distributors Profiles

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Oral OTC Analgesics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-16Y2908

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions